Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
Lokhorst, Henk M, Plesner, Torben, Laubach, Jacob P, Nahi, Hareth, Gimsing, Peter, Hansson, Markus, Minnema, Monique C, Lassen, Ulrik, Krejcik, Jakub, Palumbo, Antonio, van de Donk, Niels W.C.J, Ahmadi, Tahamtan, Khan, Imran, Uhlar, Clarissa M, Wang, Jianping, Sasser, A. Kate, Losic, Nedjad, Lisby, Steen, Basse, Linda, Brun, Nikolai, Richardson, Paul G
Published in The New England journal of medicine (24.09.2015)
Published in The New England journal of medicine (24.09.2015)
Get full text
Journal Article
Nickel‐induced proliferation of both memory and naive T cells in patch test‐negative individuals
LISBY, S, HANSEN, L. H, MENNE, T, BAADSGAARD, O
Published in Clinical and experimental immunology (01.08.1999)
Published in Clinical and experimental immunology (01.08.1999)
Get full text
Journal Article
Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis
Allen, M H, Wakelin, S H, Holloway, D, Lisby, S, Baadsgaard, O, Barker, J N, McFadden, J P
Published in Immunogenetics (New York) (01.03.2000)
Published in Immunogenetics (New York) (01.03.2000)
Get full text
Journal Article
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Dimopoulos, Meletios A, Oriol, Albert, Nahi, Hareth, San-Miguel, Jesus, Bahlis, Nizar J, Usmani, Saad Z, Rabin, Neil, Orlowski, Robert Z, Komarnicki, Mieczyslaw, Suzuki, Kenshi, Plesner, Torben, Yoon, Sung-Soo, Ben Yehuda, Dina, Richardson, Paul G, Goldschmidt, Hartmut, Reece, Donna, Lisby, Steen, Khokhar, Nushmia Z, O’Rourke, Lisa, Chiu, Christopher, Qin, Xiang, Guckert, Mary, Ahmadi, Tahamtan, Moreau, Philippe
Published in The New England journal of medicine (06.10.2016)
Published in The New England journal of medicine (06.10.2016)
Get full text
Journal Article
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
Lonial, Sagar, Prof, Weiss, Brendan M, Prof, Usmani, Saad Z, Prof, Singhal, Seema, Prof, Chari, Ajai, Prof, Bahlis, Nizar J, Prof, Belch, Andrew, Prof, Krishnan, Amrita, Prof, Vescio, Robert A, Prof, Mateos, Maria Victoria, Prof, Mazumder, Amitabha, Prof, Orlowski, Robert Z, Prof, Sutherland, Heather J, Prof, Bladé, Joan, Prof, Scott, Emma C, Prof, Oriol, Albert, MD, Berdeja, Jesus, MD, Gharibo, Mecide, Prof, Stevens, Don A, MD, LeBlanc, Richard, Prof, Sebag, Michael, Prof, Callander, Natalie, Prof, Jakubowiak, Andrzej, Prof, White, Darrell, Prof, de la Rubia, Javier, Prof, Richardson, Paul G, Prof, Lisby, Steen, MD, Feng, Huaibao, PhD, Uhlar, Clarissa M, PhD, Khan, Imran, MD, Ahmadi, Tahamtan, MD, Voorhees, Peter M, Prof
Published in The Lancet (British edition) (09.04.2016)
Published in The Lancet (British edition) (09.04.2016)
Get full text
Journal Article
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
Hillmen, Peter, Prof, Robak, Tadeusz, MD, Janssens, Ann, MD, Babu, K Govind, MD, Kloczko, Janusz, MD, Grosicki, Sebastian, MD, Doubek, Michael, MD, Panagiotidis, Panagiotis, MD, Kimby, Eva, MD, Schuh, Anna, MD, Pettitt, Andrew R, MRCPath, Boyd, Thomas, MD, Montillo, Marco, MD, Gupta, Ira V, MD, Wright, Oliver, BSc, Dixon, Iestyn, BSc, Carey, Jodi L, RN BSN, Chang, Chai-Ni, MS, Lisby, Steen, MD, McKeown, Astrid, PhD, Offner, Fritz, MD
Published in The Lancet (British edition) (09.05.2015)
Published in The Lancet (British edition) (09.05.2015)
Get full text
Journal Article
75P Efficacy and updated safety results from pivotal phase II trial 201 of naxitamab (Hu3F8): A humanized GD2-targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) neuroblastoma (NB)
Mora, J., Chan, G.C., Morgenstern, D.A., Nysom, K., Bear, M., Dalby, L. Worsaae, Lisby, S., Kushner, B.H.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article
74P Pivotal trial 201 data on outpatient administration of naxitamab (Hu3F8), a humanized GD2 targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) neuroblastoma (NB)
Morgenstern, D.A., Mora, J., Chan, G.C., Nysom, K., Bear, M., Dalby, L. Worsaae, Lisby, S., Kushner, B.H.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article
Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study
Wierda, William G., Padmanabhan, Swaminathan, Chan, Geoffrey W., Gupta, Ira V., Lisby, Steen, Österborg, Anders
Published in Blood (10.11.2011)
Published in Blood (10.11.2011)
Get full text
Journal Article
Intercellular adhesion molecule-I (ICAM-I) expression correlated to inflammation
Lisby, S, Ralfkiaer, E, Rothlein, R, Vejlsgaard, G L
Published in British journal of dermatology (1951) (01.04.1989)
Published in British journal of dermatology (1951) (01.04.1989)
Get more information
Journal Article
Nickel-induced activation of T cells in individuals with negative patch test to nickel sulphate
LISBY, S, HANSEN, L. H, SKOV, L, MENNE, T, BAADSGAARD, O
Published in Archives of Dermatological Research (01.05.1999)
Published in Archives of Dermatological Research (01.05.1999)
Get full text
Journal Article
Levels of Enzymatic Antioxidants Activities in Mononuclear Cells and Skin Reactivity to Sodium Dodecyl Sulphate
Camera, E., Lisby, S., Dell'Anna, M.L., Santucci, B., Paganelli, R., Baadsgaard, O., Picardo, M.
Published in International journal of immunopathology and pharmacology (01.01.2003)
Published in International journal of immunopathology and pharmacology (01.01.2003)
Get full text
Journal Article
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Dimopoulos, Meletios A., Oriol, Albert, Nahi, Hareth, San-Miguel, Jesus, Bahlis, Nizar J., Usmani, Saad Z., Rabin, Neil, Orlowski, Robert Z., Komarnicki, Mieczyslaw, Suzuki, Kenshi, Plesner, Torben, Yoon, Sung-Soo, Ben Yehuda, Dina, Richardson, Paul G., Goldschmidt, Hartmut, Reece, Donna, Lisby, Steen, Khokhar, Nushmia Z., O’Rourke, Lisa, Chiu, Christopher, Qin, Xiang, Guckert, Mary, Ahmadi, Tahamtan, Moreau, Philippe
Published in The New England journal of medicine (06.10.2016)
Published in The New England journal of medicine (06.10.2016)
Get full text
Journal Article
A phase I/II safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors
Chenard-Poirier, M., Hong, D.S., Coleman, R., de Bono, J., Mau-Sorensen, M., Collins, D., Lisby, S., Basse, L., Lassen, U.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
A phase I/II safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors
Chenard-Poirier, M., Hong, D.S., Coleman, R., de Bono, J., Mau-Sorensen, M., Collins, D., Lisby, S., Basse, L., Lassen, U.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma
Kim, Youn H., Duvic, Madeleine, Obitz, Erik, Gniadecki, Robert, Iversen, Lars, Österborg, Anders, Whittaker, Sean, Illidge, Timothy M., Schwarz, Thomas, Kaufmann, Roland, Cooper, Kevin, Knudsen, Kim M., Lisby, Steen, Baadsgaard, Ole, Knox, Susan J.
Published in Blood (01.06.2007)
Published in Blood (01.06.2007)
Get full text
Journal Article
A phase IIa study of tisotumab vedotin (HuMax®-TF-ADC) in patients with relapsed, recurrent and/or metastatic cervical cancer
Vergote, I., Dean, E., Lassen, U., de Bono, J., Drew, Y., Machiels, J-P., Nielsen, D., Arkenau, H-T., Forster, M., Jones, R., Slomovitz, B., Spicer, J., Johnson, M., Cornez, N., Gennigens, C., Fulton, B., Lisby, S., Basse, L., Coleman, R., Hong, D.S.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Phase III, randomized study of ofatumumab versus physicians' choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia
Österborg, Anders, Udvardy, Miklós, Zaritskey, Andrey, Andersson, Per-Ola, Grosicki, Sebastian, Mazur, Grzegorz, Kaplan, Polina, Steurer, Michael, Schuh, Anna, Montillo, Marco, Kryachok, Iryna, Middeke, Jan Moritz, Kulyaba, Yaroslav, Rekhtman, Grygoriy, Gorczyca, Michele, Daly, Siobhan, Chang, Chai-Ni, Lisby, Steen, Gupta, Ira
Published in Leukemia & lymphoma (01.09.2016)
Published in Leukemia & lymphoma (01.09.2016)
Get full text
Journal Article